Literature DB >> 6250829

7-S collagen: characterization of an unusual basement membrane structure.

J Risteli, H P Bächinger, J Engel, H Furthmayr, R Timpl.   

Abstract

A new type of collageneous structure, tentatively named 7-S collagen, was isolated from a mouse tumor basement membrane, mouse and human placenta, bovine lens capsule and human kidney. The protein was solubilized from the tissues by limited digestion with pepsin or trypsin and could easily be separated from other collageneous protein because of its resistance towards further degradation by bacterial collagenase at 20 degrees C. 7-S collagen showed an amino acid composition typical of basement membrane collagen and contained 22% carbohydrate mainly as glucosyl-galactosyl bound to hydroxylysine but also some mannose and glucosamine. Ultracentrifugal analysis demonstrated that the proteins were homogeneous with a sedimentation coefficient of about 7.2 S and with a molecular weight of about 360,000 both in phosphate buffer pH 7 and 6 M guanidine. The peptide was triple helical as shown by circular dichroism and exhibited a biphasic melting profile indicating two conformationally distinct domains with tm = 48 degrees C and 70 degrees C. The more stable domain could be isolated as an homogeneous fragment (Mr = 225,000) after a second digestion with collagenase at 37 degrees C. This fragment contained all the disulfide bonds (42 Cys/1,000 residues) of the original molecule. Electron microscopy showed a rod-like structure in agreement with the hydrodynamic properties of 7-S collagen. The dimensions of these peptides were 3 X 95 nm (long form) and 2.4 X 40-50 nm (short form). Complete reduction of 7-S collagen under denaturing conditions produced several polypeptide chains in the molecular weight range of 27,000-153,000 which differ from each other by Mr increments 25,000-27,000. Separation of the chains on agarose did not reveal any simple stoichiometric relationship indicating that some chains are either cross-linked or represent fragments produced during proteolytic treatments. Complete reduction of 7-S collagen under non-denaturing conditions lowered the thermal transiton of the triple helix to 48 degrees C but did not change its molecular weight except when exposed to dissociating solvents. 7-S collagens were potent immunogens and could be characterized by radioimmunoassays. Antigenicity was slightly reduced by reduction and denaturation while collagenase at 37 degrees C produced a larger decrease. Proteins obtained from various sources showed distinct immunological relationships although interspecies differences in affinity exist. No or only little cross-reaction was observed with type IV and V collagens and some further fragments of basement membrane collagen. The data indicate that 7-S collagen is a unique component of basement membranes which shows a more compact and stable structure than other collageneous proteins.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6250829     DOI: 10.1111/j.1432-1033.1980.tb04717.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  67 in total

1.  Distribution of basement membrane anchoring molecules in normal and transformed endometrium: altered expression of laminin gamma2 chain and collagen type XVII in endometrial adenocarcinomas.

Authors:  Marko Määttä; Sirpa Salo; Kaisa Tasanen; Ylermi Soini; Annikki Liakka; Leena Bruckner-Tuderman; Helena Autio-Harmainen
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

2.  Post-translationally abnormal collagens of prolyl 3-hydroxylase-2 null mice offer a pathobiological mechanism for the high myopia linked to human LEPREL1 mutations.

Authors:  David M Hudson; Kyu Sang Joeng; Rachel Werther; Abbhirami Rajagopal; MaryAnn Weis; Brendan H Lee; David R Eyre
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

3.  Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide.

Authors:  C Hirayama; H Suzuki; A Takada; K Fujisawa; K Tanikawa; S Igarashi
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

4.  Characterization of a non-fibrillar-related collagen in the mollusc Haliotis tuberculata and its biological activity on human dermal fibroblasts.

Authors:  Christophe Fleury; Antoine Serpentini; Magdalini Kypriotou; Emmanuelle Renard; Philippe Galéra; Jean-Marc Lebel
Journal:  Mar Biotechnol (NY)       Date:  2011-01-27       Impact factor: 3.619

5.  Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV.

Authors:  Alberto J López-Jiménez; Trayambak Basak; Roberto M Vanacore
Journal:  J Biol Chem       Date:  2017-09-01       Impact factor: 5.157

6.  Characterization of the perivascular reticulin network in a case of primary brain lymphoma. Immunohistochemical demonstration of collagen types I, III, IV, and V; laminin; and fibronectin.

Authors:  H Kalimo; M Lehto; K Näntö-Salonen; M Jalkanen; L Risteli; J Risteli; E V Narva
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

7.  Regulation of type IV collagen gene expression and degradation in fast and slow muscles during dexamethasone treatment and exercise.

Authors:  A M Ahtikoski; E-M Riso; S O A Koskinen; J Risteli; T E S Takala
Journal:  Pflugers Arch       Date:  2003-12-18       Impact factor: 3.657

Review 8.  Lens capsule as a model to study type IV collagen.

Authors:  Christopher F Cummings; Billy G Hudson
Journal:  Connect Tissue Res       Date:  2014 Jan-Feb       Impact factor: 3.417

9.  Genes of laminin B1 chain, alpha 1 (IV) chain of type IV collagen, and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas.

Authors:  Y Soini; P Pääkkö; H Autio-Harmainen
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome.

Authors:  J Wieslander; P Bygren; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.